Lapa Constantin, Maya Yoshifumi, Wagner Martin, Arias-Loza Paula, Werner Rudolf A, Herrmann Ken, Higuchi Takahiro
a Department of Nuclear Medicine , University Hospital Würzburg , Würzburg , Germany.
b Research Centre , Nihon Medi-Physics Co Ltd , Chiba , Japan.
Ann Med. 2015;47(7):538-45. doi: 10.3109/07853890.2015.1085126. Epub 2015 Oct 29.
Brown adipose tissue (BAT) attracts growing interest as a potential therapeutic target for obesity and diabetes. Hyperthyroidism is well-known to increase BAT activity, but the role of hypothyroidism is controversial. We aimed to investigate the association between different thyroid hormone (TH) states and BAT activity.
FDG-PET studies were retrospectively evaluated in thyroid cancer patients after total thyroidectomy both at euthyroidism during TH replacement or at hypothyroidism after TH cessation. Serum TH levels were compared between patients with active BAT and control patients with non-active BAT matched for age, gender, and body mass index. Additionally, animal experiments with controls (n = 5) and hypothyroid rats (n = 5) were performed.
Out of 124 patients, 6 patients with active BAT were identified. These patients showed significantly higher thyroid-stimulating hormone (TSH) levels than matched controls (P < 0.05). In animal experiments, all hypothyroid animals showed BAT activation at room temperature (24 °C), whereas controls did not (P < 0.001). Increased BAT activity was also confirmed by increased expression of UCP-1 and D2.
Increased BAT metabolism appears to be related with hypothyroidism, which might be the result of a feedback mechanism to maintain body temperature in a state of reduced basal thermogenesis. Future research needs to explore the underlying mechanistic and biological implications.
棕色脂肪组织(BAT)作为肥胖和糖尿病潜在的治疗靶点,正吸引着越来越多的关注。众所周知,甲状腺功能亢进会增加BAT活性,但甲状腺功能减退的作用存在争议。我们旨在研究不同甲状腺激素(TH)状态与BAT活性之间的关联。
对甲状腺癌患者在全甲状腺切除术后进行回顾性评估,分别在甲状腺激素替代治疗后的甲状腺功能正常期以及甲状腺激素停药后的甲状腺功能减退期进行氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)研究。比较有活性BAT的患者与年龄、性别和体重指数相匹配的无活性BAT对照患者的血清TH水平。此外,进行了对照动物(n = 5)和甲状腺功能减退大鼠(n = 5)的动物实验。
在124例患者中,识别出6例有活性BAT的患者。这些患者的促甲状腺激素(TSH)水平显著高于匹配的对照组(P < 0.05)。在动物实验中,所有甲状腺功能减退的动物在室温(24°C)下均表现出BAT激活,而对照组则未出现(P < 0.001)。解偶联蛋白1(UCP-1)和脱碘酶2(D2)表达增加也证实了BAT活性增强。
BAT代谢增加似乎与甲状腺功能减退有关,这可能是在基础产热减少状态下维持体温的一种反馈机制的结果。未来的研究需要探索其潜在的机制和生物学意义。